{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:50:21Z","timestamp":1768294221429,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Research and Development Program of Hubei Province","award":["2022BAA037"],"award-info":[{"award-number":["2022BAA037"]}]},{"name":"Fundamental Research Funds for the Central Universities, South-Central Minzu University","award":["CZQ24015"],"award-info":[{"award-number":["CZQ24015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"DOI":"10.1186\/s13321-025-01087-0","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:10:14Z","timestamp":1758877814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multi-modal contrastive drug synergy prediction model guided by single modality"],"prefix":"10.1186","volume":"17","author":[{"given":"Tong","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-gan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"13","key":"1087_CR1","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1200\/JCO.2002.12.116","volume":"20","author":"CM Kruijtzer","year":"2002","unstructured":"Kruijtzer CM, Beijnen JH, Rosing H et al (2002) Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918. J Clin Oncol 20(13):2943\u20132950","journal-title":"J Clin Oncol"},{"issue":"2","key":"1087_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd2683","volume":"8","author":"J Jia","year":"2009","unstructured":"Jia J, Zhu F, Ma X et al (2009) Mechanisms of drug combinations: interaction and network perspectives. Nat Rev Drug Discov 8(2):111\u2013128","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"1087_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.pharmthera.2013.01.016","volume":"138","author":"P Csermely","year":"2013","unstructured":"Csermely P, Korcsm\u00e1ros T, Kiss HJ et al (2013) Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther 138(3):333\u2013408","journal-title":"Pharmacol Ther"},{"issue":"2","key":"1087_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020178","volume":"13","author":"F Azam","year":"2021","unstructured":"Azam F, Vazquez A (2021) Trends in phase II trials for cancer therapies. Cancers (Basel) 13(2):178","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1087_CR5","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/s41467-019-09186-x","volume":"10","author":"F Cheng","year":"2019","unstructured":"Cheng F, Kovacs IA, Barabasi AL (2019) Network-based prediction of drug combinations. Nat Commun 10(1):1197","journal-title":"Nat Commun"},{"issue":"13","key":"1087_CR6","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1158\/0008-5472.CAN-17-0489","volume":"77","author":"SL Holbeck","year":"2017","unstructured":"Holbeck SL, Camalier R, Crowell JA et al (2017) The national cancer institute ALMANAC: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity. Cancer Res 77(13):3564\u20133576","journal-title":"Cancer Res"},{"issue":"6","key":"1087_CR7","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","volume":"15","author":"J O'Neil","year":"2016","unstructured":"O\u2019Neil J, Benita Y, Feldman I et al (2016) An unbiased oncology compound screen to identify novel combination strategies. Mol Cancer Ther 15(6):1155\u20131162","journal-title":"Mol Cancer Ther"},{"issue":"7899","key":"1087_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-022-04437-2","volume":"603","author":"P Jaaks","year":"2022","unstructured":"Jaaks P, Coker EA, Vis DJ et al (2022) Effective drug combinations in breast, colon and pancreatic cancer cells. Nature 603(7899):166\u2013173","journal-title":"Nature"},{"issue":"D1","key":"1087_CR9","first-page":"D871","volume":"48","author":"H Liu","year":"2020","unstructured":"Liu H, Zhang WH, Zou B et al (2020) Drugcombdb: a comprehensive database of drug combinations toward the discovery of combinatorial therapy. Nucleic Acids Res 48(D1):D871\u2013D881","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1087_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/wsbm.51","volume":"2","author":"JD Feala","year":"2010","unstructured":"Feala JD, Cortes J, Duxbury PM et al (2010) Systems approaches and algorithms for discovery of combinatorial therapies. Wiley Interdiscip Rev Syst Biol Med 2(2):181\u2013193","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"39","key":"1087_CR11","doi-asserted-by":"publisher","first-page":"63995","DOI":"10.18632\/oncotarget.11745","volume":"7","author":"X Sun","year":"2016","unstructured":"Sun X, Bao J, You Z et al (2016) Modeling of signaling crosstalk-mediated drug resistance and its implications on drug combination. Oncotarget 7(39):63995\u201364006","journal-title":"Oncotarget"},{"issue":"2","key":"1087_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bib\/bbw104","volume":"19","author":"SA Madani Tonekaboni","year":"2018","unstructured":"Madani Tonekaboni SA, Soltan Ghoraie L, Manem VSK et al (2018) Predictive approaches for drug combination discovery in cancer. Brief Bioinform 19(2):263\u2013276","journal-title":"Brief Bioinform"},{"issue":"11","key":"1087_CR13","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1093\/jamia\/ocab162","volume":"28","author":"J Yang","year":"2021","unstructured":"Yang J, Xu Z, Wu WKK et al (2021) Graphsynergy: a network-inspired deep learning model for anticancer drug combination prediction. J Am Med Inform Assoc 28(11):2336\u20132345","journal-title":"J Am Med Inform Assoc"},{"issue":"10","key":"1087_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btad607","volume":"39","author":"Y Gan","year":"2023","unstructured":"Gan Y, Huang X, Guo W et al (2023) Predicting synergistic anticancer drug combination based on low-rank global attention mechanism and bilinear predictor. Bioinformatics 39(10):btad607","journal-title":"Bioinformatics"},{"issue":"3","key":"1087_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad167","volume":"24","author":"G Zhang","year":"2023","unstructured":"Zhang G, Gao Z, Yan C et al (2023) KGANSynergy: knowledge graph attention network for drug synergy prediction. Brief Bioinform 24(3):bbad167","journal-title":"Brief Bioinform"},{"issue":"9","key":"1087_CR16","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","volume":"34","author":"K Preuer","year":"2018","unstructured":"Preuer K, Lewis RPI, Hochreiter S et al (2018) Deepsynergy: predicting anti-cancer drug synergy with deep learning. Bioinformatics 34(9):1538\u20131546","journal-title":"Bioinformatics"},{"issue":"16","key":"1087_CR17","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1093\/bioinformatics\/btaa287","volume":"36","author":"Z Sun","year":"2020","unstructured":"Sun Z, Huang S, Jiang P et al (2020) DTF: deep tensor factorization for predicting anticancer drug synergy. Bioinformatics 36(16):4483\u20134489","journal-title":"Bioinformatics"},{"issue":"1","key":"1087_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab390","volume":"23","author":"J Wang","year":"2022","unstructured":"Wang J, Liu X, Shen S et al (2022) DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations. Brief Bioinform 23(1):bbab390","journal-title":"Brief Bioinform"},{"issue":"7","key":"1087_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103625","volume":"28","author":"H Liu","year":"2023","unstructured":"Liu H, Fan Z, Lin J et al (2023) The recent progress of deep-learning-based in silico prediction of drug combination. Drug Discov Today 28(7):103625","journal-title":"Drug Discov Today"},{"issue":"Suppl 18","key":"1087_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12859-018-2509-3","volume":"19","author":"F Xia","year":"2018","unstructured":"Xia F, Shukla M, Brettin T et al (2018) Predicting tumor cell line response to drug pairs with deep learning. BMC Bioinformatics 19(Suppl 18):486","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"1087_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13321-023-00690-3","volume":"15","author":"M Xu","year":"2023","unstructured":"Xu M, Zhao X, Wang J et al (2023) DFFNDDS: prediction of synergistic drug combinations with dual feature fusion networks. J Cheminform 15(1):33","journal-title":"J Cheminform"},{"issue":"8","key":"1087_CR22","doi-asserted-by":"publisher","first-page":"btad438","DOI":"10.1093\/bioinformatics\/btad438","volume":"39","author":"F Rafiei","year":"2023","unstructured":"Rafiei F, Zeraati H, Abbasi K et al (2023) DeepTraSynergy: drug combinations using multimodal deep learning with transformers. Bioinformatics 39(8):btad438","journal-title":"Bioinformatics"},{"issue":"5","key":"1087_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac302","volume":"23","author":"J Hu","year":"2022","unstructured":"Hu J, Gao J, Fang X et al (2022) DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations. Brief Bioinform 23(5):bbac302","journal-title":"Brief Bioinform"},{"key":"1087_CR24","doi-asserted-by":"crossref","unstructured":"Xiong Y, Zhang Z, Chen XG. Improving deep learning model for drug synergy prediction via topological features. In IEEE international conference on bioinformatics and biomedicine (BIBM), Lisbon, Portugal, 2024. pp. 1269\u20131274.","DOI":"10.1109\/BIBM62325.2024.10822801"},{"issue":"D1","key":"1087_CR25","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC et al (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46(D1):D1074\u2013D1082","journal-title":"Nucleic Acids Res"},{"issue":"7391","key":"1087_CR26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N et al (2012) The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483(7391):603\u2013607","journal-title":"Nature"},{"key":"1087_CR27","doi-asserted-by":"crossref","unstructured":"Schlichtkrull M, Kipf TN, Bloem P, et al. Modeling Relational Data with Graph Convolutional Networks. In European Semantic Web Conference, Heraklion, Greece, 2018.","DOI":"10.1007\/978-3-319-93417-4_38"},{"key":"1087_CR28","first-page":"659","volume-title":"UniS-MMC: multimodal Classification via Unimodality-supervised Multimodal Contrastive Learning. In Association for Computational Linguistics: ACL","author":"H Zou","year":"2023","unstructured":"Zou H, Shen M, Chen M et al (2023) UniS-MMC: multimodal Classification via Unimodality-supervised Multimodal Contrastive Learning. In Association for Computational Linguistics: ACL. Canada, Toronto, pp 659\u2013672"},{"issue":"20","key":"1087_CR29","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.1093\/bioinformatics\/btac579","volume":"38","author":"X Liu","year":"2022","unstructured":"Liu X, Song C, Liu S et al (2022) Multi-way relation-enhanced hypergraph representation learning for anti-cancer drug synergy prediction. Bioinformatics 38(20):4782\u20134789","journal-title":"Bioinformatics"},{"issue":"4","key":"1087_CR30","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1109\/TCBB.2021.3086702","volume":"19","author":"HI Kuru","year":"2022","unstructured":"Kuru HI, Tastan O, Cicek AE (2022) Matchmaker: a deep learning framework for drug synergy prediction. IEEE\/ACM Trans Comput Biol Bioinform 19(4):2334\u20132344","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"1087_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.698477","volume":"12","author":"XG Chen","year":"2021","unstructured":"Chen XG, Zhang W, Yang XF et al (2021) ACP-DA: improving the prediction of anticancer peptides using data augmentation. Front Genet 12:698477","journal-title":"Front Genet"},{"key":"1087_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107355","volume":"165","author":"XG Chen","year":"2023","unstructured":"Chen XG, Yang X, Li C et al (2023) Non-coding RNA identification with pseudo RNA sequences and feature representation learning. Comput Biol Med 165:107355","journal-title":"Comput Biol Med"},{"issue":"2","key":"1087_CR33","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1109\/TCBB.2020.3021800","volume":"19","author":"XG Chen","year":"2022","unstructured":"Chen XG, Liu S, Zhang W (2022) Predicting coding potential of RNA sequences by solving local data imbalance. IEEE ACM Trans Comput Biol Bioinform 19(2):1075\u20131083","journal-title":"IEEE ACM Trans Comput Biol Bioinform"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-025-01087-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13321-025-01087-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-025-01087-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:10:16Z","timestamp":1758877816000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-025-01087-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1087"],"URL":"https:\/\/doi.org\/10.1186\/s13321-025-01087-0","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}